According to Australian Clinical Labs latest financial reports the cash on hand of ACL is $13.50M, an decrease of -24.33% to 2022. At the end of 2022 company had $17.84M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $13.50M | -24.33% |
2022 | $17.84M | -25.15% |
2021 | $23.84M | 252.33% |
2020 | $6.77M | - |